Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cellebrite DI (CLBT) Equity Ratio (2020 - 2025)

Cellebrite DI's Equity Ratio history spans 6 years, with the latest figure at 0.52 for Q4 2025.

  • Quarterly Equity Ratio rose 6.02% to 0.52 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.52 through Dec 2025, up 6.02% year-over-year, with the annual reading at 0.52 for FY2025, 6.02% up from the prior year.
  • Equity Ratio came in at 0.52 for Q4 2025, down from 0.54 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.54 in Q3 2025 to a low of 0.22 in Q4 2021.
  • The 5-year median for Equity Ratio is 0.14 (2022), against an average of 0.23.
  • Year-over-year, Equity Ratio tumbled 223.28% in 2021 and then skyrocketed 1114.53% in 2025.
  • Cellebrite DI's Equity Ratio stood at 0.22 in 2021, then surged by 184.85% to 0.18 in 2022, then crashed by 64.95% to 0.06 in 2023, then soared by 657.9% to 0.49 in 2024, then rose by 6.02% to 0.52 in 2025.
  • Per Business Quant, the three most recent readings for CLBT's Equity Ratio are 0.52 (Q4 2025), 0.54 (Q3 2025), and 0.52 (Q2 2025).